Immumem Therapeutics engages in development of best-in-class scalable and affordable allogeneic iPSC-derived cell therapies using a novel immunological memory platform against lethal cancer types by directly combating their relapse.
Org chart
Collapse
No reports!
Teams
This company has no teams yet
Offices
This company has no offices yet
